Search
Now showing items 1-8 of 8
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access
Preprint
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
| Date Issued:
2021 | Copyright:
open access
Article
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
| Date Issued:
2022 | Copyright:
open access
Article
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Article
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Article
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
| Date Issued:
2022 | Copyright:
open access